Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer
Open Access
- 20 November 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-23
Abstract
Overcoming resistance to therapy is a major challenge in castration-resistant prostate cancer (CRPC). Lineage plasticity towards a neuroendocrine phenotype enables CRPC to adapt and survive targeted therapies. However, the molecular mechanisms of epigenetic reprogramming during this process are still poorly understood. Here we show that the protein kinase PKCλ/ι-mediated phosphorylation of enhancer of zeste homolog 2 (EZH2) regulates its proteasomal degradation and maintains EZH2 as part of the canonical polycomb repressive complex (PRC2). Loss of PKCλ/ι promotes a switch during enzalutamide treatment to a non-canonical EZH2 cistrome that triggers the transcriptional activation of the translational machinery to induce a transforming growth factor β (TGFβ) resistance program. The increased reliance on protein synthesis creates a synthetic vulnerability in PKCλ/ι-deficient CRPC.Keywords
Funding Information
- Foundation for the National Institutes of Health (R01CA246765, R01CA277857, R50CA283476, R50CA265332)
This publication has 69 references indexed in Scilit:
- The translational landscape of mTOR signalling steers cancer initiation and metastasisNature, 2012
- Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2Nature Cell Biology, 2010
- eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionProceedings of the National Academy of Sciences, 2010
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4ECancer Cell, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Transcriptional profiling of transurethral resection samples provides insight into molecular mechanisms of hormone refractory prostate cancerProstate Cancer and Prostatic Diseases, 2007
- Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3Science, 2005
- Inhibition of Translation in Eukaryotic Systems by HarringtonineEuropean Journal of Biochemistry, 1977